PERSISTENCE OF HOST-TYPE HEMATOPOIESIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA IS SIGNIFICANTLY RELATED TO THE RECIPIENTS AGE AND/OR THE CONDITIONING REGIMEN, BUT IT IS NOT ASSOCIATED WITH AN INCREASED RISK OF RELAPSE